Steinberg JS, Varma N, Cygankiewicz I, Aziz P, Balsam P, Baranchuk A, Cantillon DJ, Dilaveris P, Dubner SJ, El-Sheriff N, Krol J, Kurepesa M, La Rovere MT, Lobodzinski SS, Locati ET, Mittal S, Olshansky B, Piotrowicz E, Saxon LA, Stone PH, Tereshchenko LG, Turritto G, Wimmer NJ, Verrier RL, Zareba W, Piotrowicz R. 2017 ISHNE-HRS Expert Consensus Statement on Ambulatory ECG and External Cardiac Monitoring/TelemetryHeart Rhythm, 2017 Jul;14(7):e55-e96.


Saxon LA. Athletic Performance Monitoring, Pseudo Science and Metaphysics Meet Ethics. Am J Bioeth 2016; 17(1):61-2.

Shinbane JS, Saxon LA. Digital monitoring and care: Virtual medicine. Trends Cardiovascul Med 2016, 26(8):722-30.    

Bristow M, Anderson S, Feldman A, Mei C, Saxon LA, DeMets D. Lessons Learned and Insights Gained in the Design, Analysis and Outcomes of the COMPANION Trial. JACC Heart Failure, 4(2016):521-535.

Chang PM, Saxon LA, Doshi RN. The Subcutaneous Implantable Cardioverter-Defibrillator as Part of Dual Device Therapy in Complex Congenital Heart Disease. The Journal of Innovations in Cardiac Rhythm Management, 7(2016):2395-2399.

Saxon LA. Mobile Health Application SolutionsCirculation, 2016 Feb;9(2) p e002477.

Konechy T, Saxon LA. Integration of Smartphone Based Monitoring - No Modality Is an Island, Entire of Itself. Journal of Cardiovascular Electrophysiology, 2(1):58-59, 2016. 


Akar JG, Bao H, Jones P, Wang Y, Varosy P, Masoudi FA, Stein K, Saxon LA, Norman ST, Curtis JP. Use of Remote Monitoring Is Associated with Lower Risk of Adverse Outcomes Among Patients with Implanted Cardiac DefibrillatorsCirculation: Arrhythmia and Electrophysiology 2015 Oct;8(5): 1173-80.

Hsu JC, Saxon LA, Jones PW, Wehrenberg S, Marcus GM. Utilization trends and clinical outcomes in patients implanted with a single-vs a dual-coil implantable cardioverter-defibrillator lead: Insights from the ALTITUDE StudyHeart Rhythm 2015 Aug; 12(8); 1770-5.

Maurer MS, Adamson PB, Costanzo MR, Eigler N, Gilbert J, Gold MR, Klapholz M, Saxon LA, Singh JP, Troughton R, Abraham W. Rationale and Design of the Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Study (LAPTOP-HF)J Card Fail 2015; 6:479-488.

Chang PM, Powell B, Jones PW, Carter N, Hayes D, Saxon LA. Implantable Cardioverter-Defibrillator Programming Characteristics, Shocked Rhythms, and Survival Among Patients Under Thirty Years of Age. Heart Rhythm, submitted, March 2015.

Haberman Z, Jahn R, Bose R, Tun H, Shinbane J, Doshi R, Chang P, Saxon LAWireless Smartphone ECG Enables Large Scale Screening in Diverse PopulationsJ Cardiovasc Electrophysiol 2015 May; 26(5):520-6. 

Cesario D, Powell B, Roosevelt G, Day J, Hayes D, Jones P, Wold N, Saxon LAThe Role of Atrial Fibrillation in CRT-D Patients: The ALTITUDE Study Group. The Journal in Innovations in Cardiac Rhythm Management 2015; 6;1873-80.


Eisenberg E, Carlson S, Doshi R, Shinbane J, Chang P, Saxon L. Chronic Ambulatory Monitoring: Results of a Large Single Center ExperienceThe Journal in Innovations in Cardiac Rhythm Management 2014; 5:1818-23.

Merchant FM, Jones P, Wehrenberg S, Lloyd MS, Saxon LA. Incidence of defibrillator shocks after elective generator exchange following uneventful first battery life. J Am Heart Assoc 2014; 3(6).

Mahajan, D., Dong, Y., Saxon, L.A., Cha, Y.M., Gilliam, F.R., 3rd, Asirvatham, S.J., Cesario, D.A., Jones, P.W., Seth, M., Powell, B.D. 2014. Performance of an Automatic Arrhythmia Classification Algorithm: Comparison to the ALTITUDE Electrophysiologist Panel Adjudications. Pacing Clin Electrophysiol. doi:10.1111/pace.12367

Chang, P.M., Doshi, R., Saxon, L.A. 2014. Subcutaneous Implantable Cardioverter-Defibrillator. Circulation 129, e644-e646. doi:10.1161/CIRCULATIONAHA.113.006645

Boehmer, J, Saxon, L, Lobban, J, Kaplan, A, Villareal, R, Mirza, I, Jones, P, Seth, M, Meyer T. Clinician Response to Remote Active Monitoring in Patients with Heart Failure: Results of the RAPID-RF TrialThe Journal of Innovations in Cardiac Rhythm Management 2014; 5:1551-60.


Akar, J.G., Bao, H., Jones, P., Wang, Y., Chaudry, S.I., Varosy, P., Masoudi, F.A., Stein, K., Saxon, L.A., Curtis, J.P. Use of remote monitoring of newly implanted cardioverter-defibrillators: insights from the patient related determinants of ICD remote monitoring (PREDICT RM) study. Circulation. 2013; 128:2372-83.

Powell BD, Saxon LA, Boehmer JP, Day JD, Gilliam FR 3rd, Heidenreich PA, et al. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study. J Am Coll Cardiol. 2013; 62:1674-9.

Saxon, LA. The subcutaneous implantable defibrillator: a new technology that raises an existential question for the implantable cardioverter-defibrillator. Circulation. 2013 Aug 27; 128(9):938-40.

Cha, Y.M., Hayes, D.L., Asirvatham, S.J., Powell, B.D., Cesario, D.A., Cao, M., Gilliam, F.R., 3rd, Jones, P.W., Jiang, S., and Saxon, L.A. 2013. Impact of shock energy and ventricular rhythm on the success of first shock therapy: the ALTITUDE first shock study. Heart Rhythm 10, 702-7.

Saxon, L.A. Ubiquitous wireless ECG recording: a powerful tool physicians should embrace. J. Cardiovasc. Electrophysiol 2013; 24:480-3.


Daubert JC, Saxon LA, et al: 2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. Europace 2012; 14(9):1236-1286.

Somma K, Bhatt DL, Fonarow GC, Cannon CP, Cox M, Laskey W, Peacock F, Hernandez AF, Peterson ED, Schwamm L, Saxon LA. Guideline adherence after ST-segment elevation versus non-ST segment elevation myocardial infarction. Circ Cardiovasc Qual Outcomes. 2012; 5:654-61.

Powell B, Asirvatham S, Perschbacher D, Jones P, Yong-Mei C, Cesario D, Cao M, Gilliam F, Saxon LA. Noise, Artifact and Oversensing Related Inappropriate ICD Shock Evaluation: ALTITUDE NOISE Study. Pacing Clin Electrophysiol, 2012; 35:863-9.

Shinbane JS, Shriki J, Hindoyan A, Chang PM, Ghosh B, Farvid A, Saxon LA, Cao M, Cesario D, Takahashi M, Colletti PM, Wilcox A, Baker C, Starnes VA. Unoperated Congenitally Corrected Transportation of the Great Arteries, Non-restrictive Ventricular Septal Defect, and Pulmonary Stenosis in Middle Adulthood: Do Multiple Wrongs Make a Right? World Journal for Pediatric and Congenital Heart Surgery. 2012; 3:123-129.


Cao M, Saxon LA. Spinal Cord Stimulation: A Triple Threat Therapy? J of Cardiac Electrophysiol, 2011; 23:541-542.

Saxon LA, Wilkoff BL. CRT or CRT-D devices? The case for 'high energy' devices. Heart Fail Rev, 2011; 17:777-9.

Cesario DA, Cao M, Cunningham M, Saxon LA, Libbus I. Arrhythmia Detection with a Low-Profile Wireless Adherent Cardiac Monitor: Results from the ADAM and EVE Studies. J of Innovations in Cardiac Rhythm Management, 2011; 2:476-482.

Fong MW, Grazette L, Cesario D, Cao M, Saxon L. Treatment of Ventricular Tachycardia in Patients with Heart Failure. Curr Cardiol Rep 2011; 13:203-209.

Hayes DL, Boehmer JP, Day J, Gilliam FR, Heindenreich PA, Seth M, Jones PW, Saxon LA. Cardiac Resynchronization Therapy and the Relationship of Percent Biventricular Packing to Symptoms and SurvivalHeart Rhythm 2011; 8:1469-75.

Gilliam FR, Hayes DL, Boehmer JP, Day J, Heindenreich PA, Seth M, Jones PW, Stein KM, Saxon LA. Real World Evaluation of Dual Zone ICD and CRT-D Programming Compared to Single zone Programming: The ALTITUDE REDUCES StudyJ of Cardiac Electrophysiol 2011; 22:1023-9.

Saxon LA. Cardiovascular care and research in the networked era. J Cardiovasc Transl Res. 2011;4:1-2.

Powell BD, Cha YM, Asirvatham SJ, Cesario DA, Cao M, Jones PW, Seth M, Saxon LA, Gilliam Iii FR. Implantable Cardioverter Defibrillator Electrogram Adjudication for Device Registries: Methodology and Observations from ALTITUDE. Pacing Clin Electrophysiol. 2011; 34:1003-12.

Orrange SE, Saxon LA, Baydur A, McFadden PM.  Unexplained cough: pericardial cyst innocent bystander or culprit? CHEST Disease Reports 2011;1:1-2.

Troughton RW, Ritzema J, Eigler NL, Melton IC, Krum H, Adamson PB, Kar S, Shah PK, Whtiting JS, Heywood JT, Rosero S, Singh JP, Saxon L, Matthews R, Crozier IG, Abraham WT. Direct left atrial pressure monitoring in severe heart failure: long-term sensor performance. J of Cardiovasc Trans Res 2011; 4:3-13.

Hindoyan A, Cao M, Cesario DA, Shinbane JS, Saxon LA. Impact of Relaxation Training on Patient Perceived Anxiety, Pain and Outcomes After Interventional Electrophysiology Procedures. Pacing Clin Electrophysiol. 2011;34:821-6.


Huang G, Pashmforoush M, Chung B, Saxon LA. The Role of Cardiac Electrophysiology in Myocardial Regenerative Stem Cell TherapyJ of Cardiovasc Trans Res 2010;4:61-65.

Cesario DA, Saxon LA, Cao MK, Bowdish M, Cunningham M. Ventricular Tachycardia in the Era of Ventricular Assist Devices. J Cardiovasc Electrophysiol 2010;22:359-363.

Saxon LA, Hayes DL, Gilliam FR, Heidenreich PA, Day J, Seth M, Meyer TE, Jones PW, Boehmer JP. Long-Term Outcome After ICD and CRT Implant and the Influence of Remote Device Follow-Up: The ALTITUDE Survival Study. Circulation 2010; 122:2359-2367.

Cesario DA, Shinbane J, Cao M, Saxon LA, Cunningham M, Essilfie G. Use of Computed Tomography Delayed Enhancement Imaging and a Ventricular Assist Device in Ablation of Recurrent Ventricular Techycardia. Innovations in Cardiac Rhythm Management 2010;1:54-58.


Cao M, Saxon LAComplete Heart Block and Preserved LV Function: Does Right Ventricular Pacing Site Matter? J Cardiovasc Electrophysiol 2009;20:901-5.

Saxon LA, Olshansky B, Volosin K, Steinberg J, Lee B, Tomassoni G, Guarnieri T, Rao A, Yong P, Galle E, Leigh J, Ecklund F, Bristow M. Influence of Left Ventricular Lead Location on Outcomes in the COMPANION Study. J Cardiovasc Electrophysiol 2009;20:764-68.


Saxon LA, Rao AK, Klarich KW. Shortage of Female Cardiologists: Exploring the Issues. Mayo Clinic Proceedings 2008;83:1022-25.

De Marco T, Wolfel E, Feldman AM, Lowes B, Higginbotham MB, Ghali JK, Wagoner L, Kirlin PC, Kennett JD, Goel S, Saxon LA, Boehmer JP, Mann D, Galle E, Ecklund F, Yong P, Bristow MR. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study. J Card Fail 2008;14:9-18.


Saxon LA, Rao AK. Body computing: how networked medical devices can solve problems facing heath care today. J Cardiovasc Electrophysiol 2007;18:1345-7.

Ghali JK, Boehmer J, Feldman AM, Saxon LA, Demarco T, Carson P, Yong P, Galle EG, Leigh J, Ecklund FL, Bristow MR. Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure. J Card Fail 2007;13:769-73.

Cao M, Shinbane JS, Gillberg JM, Saxon LA. Taser-induced rapid ventricular myocardial capture demonstrated by pacemaker intracardiac electrograms. J Cardiovasc Electrophysiol 2007;18:876-79.

Saxon LA, Boehmer JP, Neuman S, Mullins CS. Remote active monitoring in patients with heart failure (RAPID-RF):Design and rationale. J Card Fail 2007;13:241-46.


Saxon LA, Bristow M, Boehmer J, Krueger S, Kass D, De Marco T, Carson P, DiCarlo L, Feldman A, Galle E, Echlund F. Predictors of sudden cardiac death and appropriate shock in the COMPANION Trial. Circulation 2006; 114:2766-72.

Saxon LA. Patient selection for primary prevention ICD's - Are EPS shocking patients into consent? J Card Fail 2006;12:413-415.

Caslon MD, Wilkoff BL, Maisel WH, Ellenbogen KA, Saxon LA, Pyrstowsky EN. Recommendations from the Heart Rhythm Society Task Force on device performance policies and guidelines. Heart Rhythm 2006;3:1250-1273.

Saxon LA. More is better with cardiac resynchronization therapy - but is it enough? Eur Heart J 2006;27:1891-92.

Saxon LA, Greenfield RA, Crandall B, Nydegger C, Orlow M, Van Genderen R. Results of the Multicenter RENEWAL 3 AVT Clinical Study of Cardiac Resynchronization Defibrillator Therapy in Patients with Atrial Fibrillation. J Cardivasc Electrophysiol 2006;17:520-25.


Feldman AM, de Lissovoy G, Bristow MR, Saxon LA, De Marco T, Kass DA, Boehmer J, Singh S, Whellan DJ, Carson P, Boscoe A, Baker TM, Gunderman MR. Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial. J Am Coll Cardiol 2005;46:2311-21.

Marcus GM, Rose E, Viloria EM, Schafer J, De Marco T, Saxon LA, Foster E. VENTAK CHF/CONTAK-CD Biventricular Pacing Study Investigators: Septal to posterior wall motion delay fails to predict reverse remodeling or clinical improvement in patients undergoing cardiac resynchronization therapy. J Am Coll Cardiol 2005;46:2208-14.

De Lurgio DB, Foster E, Higginbotham MB, Larntz K, Saxon LA. A comparison of cardiac resynchronization by sequential biventricular pacing and left ventricular pacing to simultaneous biventricular pacing: rationale and design of the DECREASE-HF clinical trial. J Card Fail 2005;11:233-39.

Saxon LA. Sudden cardiac death:epidemiology and temporal trends. Rev Cardiovasc Med 2005;6:S12-20.


Horwich T, Foster E, De Marco T, Tseng Z & Saxon LA. Effects of Resynchronization Therapy on Cardiac Function in Pacemaker Patients "Upgraded" to Biventricular Devices. J Cardiovasc Electrophysiol 2004;15:1-6.

Steinberg JS, Maniar PB, Higgins SL, Whiting SL, Meyer DB, Dubner S, Shah AH, Huang DT, Saxon LA. Noninvasive assessment of biventricular pacing system. Ann Noninvasive Electrocardiol 2004;9:58-70.

Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, DeMarco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM. Comparison of Medical Therapy, Pacing and Defibrillation Heart Failure (COMPANION) investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-50.


Hayes DL, Naccarelli GV, Furman S, Parsonnet V, Reynolds D, Goldschlager N, Gillette P, Maloney J, Saxon LA, Leon A, Daoud E. NASPE training requirements for cardiac implantable electronic devices: selection, implantation and follow-up. North American Society of Pacing and Electrophysiology. Pacing Clin Electrophysiol 2003;26:1556-62.

Saxon LA, Ellenbogen KA. Resynchronization therapy for the treatment of heart failure. Circulation 2003;108:1044-48.

Horwich T, Lee SJ, Saxon LA. Usefulness of QRS prolongation in predicting risk of inducible monomorphic ventricular tachycardia in patients referred for electrophysiologic studies. Am J Cardiol 2003;92:804-9.

Higgins SL, Hummel JD, Niazi IK, Giudici MC, Worley SJ, Saxon LA, Boehmer JP, Higginbotham MB, DeMarco TA, Foster E, Yong PG. MSEE for the Ventak CHF/CONTAK CD Biventricular Pacing Study Investigators. Cardiac Resynchronization Therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrythmias. J Am Coll Cardiol 2003;42:1454-59.

Lee SJ, MuCulloch C, Mangat I, Foster E, De Marco T, Saxon LA. Isolated bundle branch block and left ventricular dysfunction. J Card Fail 2003;9:87-92.

Kumar UN, Saxon LA. Ventricular resynchronization: a promising therapy for heart failure. Am J Geriatr Cardiol 2003;12:41-48.


Saxon LA, De Marco T, Schafer J, Chatterjee K, Kumar UN, Foster E. VIGOR-CHF Investigators: Effects of chronic biventricular stimulation for resynchronization on echocardiographic measures of remodeling. Circulation 2002;105:1304-10.

Saxon LA. The MIRACLE Trial: an electrophysiologists perspective. J Card Fail 8:202-203,2002.

Saxon LA. Heart Failure and Implantable Cardioverter Defibrillator (ICD) Therapy: Update and Perspective on Current Primary Prevention Trials. J Card Fail 2002;8:161-66.

Saxon LA, De Marco T. Arrhythmias associated with dilated cardiomyopathy. Card Electrophysiol Rev 2002;6:18-25.


Saxon LA, De Marco T. Cardiac Resynchronization: A cornerstone in the foundation of device therapy in heart failure. Editorial comment. J Am Coll Cardiol 2001;38:1971-73.


Saxon LA, Kumar UN, De Marco T. Cardiomyopathy and Arrhythmia Research and Education (CARE) Center. Heart failure and cardiac resynchronization therapies-the U.S. experience in the year 2000. Ann Noninvasive Electrocardiol 2000;5:188-194.

Viskin S, Glikson M, Fish R, Glick A, Copperman Y, Saxon LA. Rate smoothing with cardiac pacing for preventing torsade de pointes. Am J Cardiol 2000;86:K111-K115.

Sippens Groenewegen A, Lesh MD, Roithinger FX, Ellis WS, Steiner PR, Saxon LA, Lee RJ, Scheinman MM. Body surface mapping of counterclockwise and clockwise typical atrial flutter: a comparative analysis with endocardial activation sequence mapping. J Am Coll Cardiol 2000; 35:1276-87.

Kerwin WF, Botvinick EH, O'Connell JW, Merrick SH, De Marco T, Chatterjee K, Scheibly K, Saxon LA. Ventricular contraction abnormalities in dilated cardiomyopathy: effect of biventricular pacing to correct interventricular dyssynchrony. J Am Coll Cardiol 2000;35:1221-27.

Bristow MR, Feldman AM, Saxon LA. COMPANION Steering Committee and Clinical Investigators: Heart failure management using implantable devices for ventricular resynchronization: comparison of medical therapy, pacing and defibrillation in chronic heart failure (COMPANION) trial. J Card Fail 2000;6:276-85.

Scheinman MM, Saxon LA. Long-term His bundle pacing and cardiac function. Circulation 2000;101:836-37.


Saxon LA. Arrhythmias Associated with Dilated Cardiomyopathy. Card Electrophysiol Rev 1999;3:187-93

Saxon LA. Predicting mode of death in heart failure. Herzschr Ektrophys 1999;10:3-6.

Saxon LA, Boehmer JP, Hummel J, Kacet S, DeMarco T, Naccarelli G, Daoud E. Vigor CHF and Ventak CHF Investigators. Biventricular pacing in patients with congestive heart failure: two prospectively randomized trials. Am J Cardiol 1999;83:120D-123D.

Roithinger FX, Cheng J, Sippens Groenewegen A, Lee RJ, Saxon LA, Scheinman MM, Lesh MD. Use of electroanatomic mapping to delineate transseptal atrial conduction in humans. Circulation 1999;100:1791-97.


Stevenson WG, Friedman PL, Kocovic D, Sager PT, Saxon LA, Pavri B. Radiofrequency catheter ablation of ventricular tachycardia after myocardial infarction. Circulation 1998;98:308-14.

Shinbane JS, Lesh MD, Stevenson WG, Ursel PU, Klitzner TS, Natterson PD, Wiener I, Ursell PC, Saxon LA. Anatomic and electrophysiologic relation between the coronary sinus and mitral annulus: implications for ablation of left-sided accessory pathway. Am Heart J 1998;135:93-98.

Saxon LA, Kerwin WF, Cahalan MK, Kalman JM, Olgin JE, Foster E, Schiller NB, Shinbane JS, Lesh MD, Merrick SH. Acute effects of intraoperative multi-site ventricular pacing on left ventricular function and activation/contraction sequence in patients with depressed ventricular function. J Cardiovasc Electrophysiol 1998;9:13-21.

Saxon LA. When to treat arrhythmias with radiofrequency catheter ablation. Contemporary Treatments in Cardiovascular Disease 1998;3:33-48.


Saxon LA. Atrial fibrillation and dilated cardiomyopathy: therapeutic strategies when sinus rhythm cannot be maintained. Pacing Clin Electrophysiol 1997;20:720-25.

Wood KA, Eisenberg SJ, Kalman JM, Drew BJ, Saxon LA, Lee RJ, Lesh MD, Scheinman MM. Risk of thromboembolism in chronic atrial flutter. Am J Cardiol 1997;79:1043-47.

Stevenson WG, Friedman PL, Sager PT, Saxon LA, Kocovic D, Harada T, Wiener I, Khan H. Exploring postinfarction reentrant ventricular tachycardia with entrainment mapping. J Am Coll Cardiol 1997;29:1180-89.

Olgin JE, Kalman JM, Saxon LA, Lee RJ, Lesh MD. Mechanism of initiation of atrial flutter in humans: site of unidirectional block and direction of rotation. J Am Coll Cardiol 1997;29:376-84.

Lesh MD, Kalman JM, Saxon LA, Dorostkar PC. Electrophysiology of "incisional" reentrant atrial tachycardia complicating surgery for congenital heart disease. Pacing Clin Electrophsyiol 1997;20:2107-111.

Kalman JM, Olgin JE, Saxon LA, Lee RJ, Scheinman MM, Lesh, MD. Electrocardiographic and electrophysiologic characterization of atypical atrial flutter in man: use of activation and entrainment mapping and implications for catheter ablation. J Cardiovasc Electrophysiol 1997;8:121-44.

Hadjis TA, Stevenson WG, Harada T, Friedman PL, Sager P, Saxon LA. Preferential locations for critical reentry circuit sites causing ventricular tachycardia after inferior wall myocardial infarction. J Cardiovasc Electrophysiol 1997;8:363-70.

Chatterjee K, De Marco T, Saxon LA, Galli FC.  Antiarrhythmic drug therapy for atrial fibrillation in dilated cardiomyopathy. Heart Fail 1997;13:17-21.


Viskin S, Alla SR, Barron HV, Heller K, Saxon LA, Kitzis I, van Hare GF, Wong MJ, Lesh MD, Scheinman MM. Mode of onset of torsade de pointes in congenital long QT syndrome. J Am Coll Cardiol 1996;28:1262-68.

Stevenson WG, Stevenson LW, Middlekauff HR, Fonarow GC, Hamilton MA, Woo MA, Saxon LA, Natterson PD, Steimle A, Walden JA, Tillisch JH. Improving survival for patients with atrial fibrillation and advanced heart failure. J Am Coll Cardiol 1996;28:1458-63.

Saxon LA, Shannon K, Wetzel GT, Endler LK, Klitzner TS. Familial long QT syndrome: electrical storm and ICD therapy. Am Heart J 1996;131:1037-39.

Kalman JM, VanHare GF, Olgin JE, Saxon LA, Stark SI, Lesh MD. Ablation of incisional tachycardia complicating surgery for congenital heart disease: use of entrainment to define a critical isthmus of conduction. Circulation 1996;93:502-12.

Kalman JK, Olgin JE, Fisher WG, Saxon LA, Lee RJ, Lesh MD. Activation and entertainment mapping defines the tricuspid annulus as the anterior barrier in typical atrial flutter. Circulation 1996;94:398-406.

Hamdan M, Van Hare G, Westby F, Gonzalez R, Dorostkar P, Lee R, Lesh M, Saxon LA, Kalman J, Scheinman M. Selective catheter ablation of the tachycardia focus in patients with nonreentrant junctional tachycardia. Am J Cardiol 1996;78:1292-97.


Stevenson WG, Stevenson LW, Middlekauff HR, Fonarow GC, Hamilton MA, Woo MA, Saxon LA, Natterson PD, Steimele A, Creaser J, Tillisch JH. Improving survival for patients with advanced heart failure: a study of 737 consecutive patients. J Am Coll Cardiol 1995;126:1417-23.

Stevenson EG, Sager PT, Natterson PD, Saxon LA, Middlekauff HR, Wiener I. Relation of pace mapping QRS configuration and conduction delay to ventricular tachycardia reentry circuits in human infarct scars. J Am Coll Cardiol 1995;26:481-88.

Saxon LA, Weiner I, Natterson PD, Laks H, Drinkwater DC, Stevenson WG. Monomorphic versus polymorphic ventricular tachycardia after coronary artery bypass grafting. Am J Cardiol 1995;75:403-405.

Saxon LA, Weiner I, DeLurgio DB, Natterson PD, Laks H, Drinkwater DC, Stevenson WG. Implantable defibrillators for high-risk patients who are awaiting cardiac transplantation. Am Heart J 1995;130:501-506.

Saxon LA, Kalman JM, Olgin JE, Scheinman MM, Lee RJ, Lesh MD. Results of radiofrequency ablation for atrial flutter. Am J Cardiol 1995;26:431-38.

Natterson PD, Stevenson WG, Saxon LA, Middlekauff HR, Stevenson LW. Risk of arterial embolization in 224 patients awaiting cardiac transplantation. Am Heart J 1995;129:564-70.

Middlekauff HR, Stevenson WF, Saxon LA, Stevenson LW. Amiodarone and torsades de pointes in heart tissue. Am J Cardiol 1995;76:501-502.


Saxon LA, Stevenson WG, Middlekauff HR, Natterson PD, Stevenson LW. Sudden death and ventricular tachycardia in advanced heart failure. Primary Cardiol 1993;19:38-43.

Chang RJ, Stevenson WG, Saxon LA, Parker J. Increasing catheter ablation lesion size by simultaneous application of radiofrequency current to two adjacent sites. Am Heart J 1993;125:1276-84.

Stevenson WG, Stevenson LW, Middlekauff HR, Saxon LA. Sudden death prevention in patients with advanced ventricular dysfunction. Circulation 1993;88:2953-61.

Stevenson WG, Middlekauff HR, Saxon LA. Management of arrhythmias in heart failure. Curr Opin Cardiol 1993;8:419-428.

Klitzner TS, Wetzel GT, Saxon LA, Stevenson WG. Radiofrequency ablation: a new era in the treatment of pediatric arrhythmias. Am J Dis Child 1993;147:769-771.

Lai WW, Al-Khatib Y, Klitzner TS, Child JS, Wetzel GT, Saxon LA, Stevenson WG, Williams RG. Biplanar transesophageal echocardiographic direction of radiofrequency catheter ablation in children and adolescents. Am J Cardiol 1993;71:872-74.

Middlekauff HR, Stevenson WG, Saxon LA. Prognosis following syncope: impact of left ventricular function. Am Heart J 1993;125:121-127.

Middlekauff HR, Stevenson WG, Stevenson LW, Saxon LA. Syncope in advanced heart failure: high risk of sudden death regardless of origin of syncope. J Am Coll Cardiol 1993;21:110-116.

Saxon LA, Stevenson WG, Fonarow GF, Middlekauff HR, Yeatman LA, Sherman CT, Child JS: Transesophageal echocardiography to guide energy delivery and catheter position during radiofrequency catheter ablation of ventricular tachycardia. Am J Cardiol 1993;72:658-661.

Saxon LA, Stevenson WG, Middlekauff HR, Fonarow G, Woo M, Moser D, Stevenson LW. Prediciting death from progressive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1993;72:62-65.

Saxon LA, Stevenson WG, Middlekauff HR, Stevenson LW. Increased risk of progressive hemodynamic deterioration in advanced heart failure patients requiring permanent pacemakers. Am Heart J 1993;125:1306-10.

Stevenson WG, Khan H, Sager P, Saxon LA, Middlekauff HR, Natterson PD, Wiener I. Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction. Circulation 1993;88:1647-70.


Chelimsky-Fallick C, Stevenson LW, Stevenson WG, Kobashigawa J, Middlekauff HR, Saxon LA, Brownfield ED, Moriuchi J, Hamilton MA, Drinkwater D, Laks H. Amiodarone therapy does not compromise subsequent cardiac transplantation. J Am Coll Cardiol 1992;20:1556-61.

Saxon LA, Sherman CT, Stevenson WG, Yeatman LA, Wiener I. Influence of residual blood flow to the infarct-related artery on ventricular tachycardia after myocardial infarction. Am J Cardiol 1992;69:554-56.

Saxon LA, Sherman CT, Stevenson WG, Yeatman LA, Wiener I. Ventricular tachycardia after infarction: sources of coronary blood flow to the infarction zone. Am Heart J 1992;124:84-87.

Stevenson WG, Middlekauff HR, Stevenson LW, Saxon LA, Woo MA, Moser D. Significance of aborted cardiac arrests and sustained ventricular tachycardia in patients referred for therapy of advanced heart failure. Am Heart J 1992;124:123-130.

Stevenson WG, Sager P, Nademanee K, Hassan H, Middlekauff HR, Saxon LA, Weiner I. Identifying sites for catheter ablation of ventricular tachycardia. Herz 1992;17:158-170.

Middlekauff HR, Weiner I, Saxon LA, Stevenson WG. Low-dose amiodarone for atrial fibrillation: time for a prospective study? Ann Intern Med 1992;116:1017-20.


Saxon LA, Albert BH, Uretz EF, Denes P. Permanent pacemaker placement in chronic atrial fibrillation associated with intermittent AV block and cerebral symptoms. Pacing and Clinical Electrophysiology 1990;13:724-29.

Saxon LA, Denes P. Long term survival of valvular heart disease patients presenting with sustained ventricular tachycardia/fibrillation. New Trends in Arrhythmias 1990;6:7-18.

Saxon LA, Buckingham TA. Clinical application of the classification of antiarrhythmic drugs. Rhythmology 1990;4:33-41.


Haake RE, Saxon LA, Bander SJ, Haake RJ. Depressed central respiratory drive causing weaning failure. Its reversal with doxapram. Chest 1989;95:695-7.

Saxon LA, Uretz EF, Denes P. Significance of clinical presentation in ventricular tachycardia. Am Heart J 1989;4:695-701.